EI
CNMD icon

EAM Investors’s CONMED CNMD Stock Holding History

EAM Investors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,525
Closed -$2.29M – 231
2019
Q4 		$2.29M Buy
20,525
+944
+5% +$101K 0.5% 60
2019
Q3 		$1.88M Buy
+19,581
New +$1.84M 0.5% 70
2018
Q4 		– Sell
-41,222
Closed -$3.27M – 260
2018
Q3 		$3.27M Sell
41,222
-3,135
-7% -$243K 0.49% 86
2018
Q2 		$3.25M Sell
44,357
-4,461
-9% -$303K 0.51% 72
2018
Q1 		$3.09M Buy
+48,818
New +$2.91M 0.51% 78
2014
Q3 		– Sell
-27,762
Closed -$1.23M – 324
2014
Q2 		$1.23M Buy
+27,762
New +$1.26M 0.23% 238

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EAM Investors's CNMD Position: Q1 2020 in Review

EAM Investors sold out of CONMED (CNMD) in Q1 2020, closing a stake of 20,525 shares — an estimated $2.29M sold.

EAM Investors first reported a position in CNMD in Q2 2014 and held it in 6 quarters. The position peaked at $3.27M in Q3 2018. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • EAM Investors reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • EAM Investors sold 20,525 CONMED shares in Q1 2020, an estimated $2.29M.
  • EAM Investors first reported a position in CONMED in Q2 2014 and held it in 6 quarters.
  • EAM Investors's CONMED position peaked at $3.27M in Q3 2018.
  • 228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.